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ABSTRACT

Since the introduction of ether as a general anesthetic, there has been a continuous quest to develop the
ideal anesthetic gas. The attributes of the ideal anesthetic gas have evolved over time. At the beginning
of the 20th century, the search for the ideal anesthetic was focused upon finding an anesthetic gas with
rapid inhalational induction and rapid emergence that could be delivered without cumbersome
apparatus and would have limited potential for toxicity.
Somnoforme was a mixture of ethyl chloride, methyl chloride, and ethyl bromide designed to provide
powerful efficacy with low potential for side effects by blending of several volatile vapors. Somnoforme
was developed by Dr. Georges Rolland, Director of the Dental School in Bordeaux and first formally
presented to the Congress of the French Association for the Advancement of Sciences on September 10,
1901. Somnoforme was rapidly embraced as the ideal general anesthetic for short operations. E. de
Trey & Sons of Philadelphia, American distributors for Somnoforme advertised it as “The Ideal General
Anesthetic for Dental and Minor Operations”.
Dr. Rolland’s intention was to blend already well-known drugs into one mixture from which the
respective advantages of each one could be obtained and corresponding effects produced without having
many of the inconveniences and the same degree of danger of the individual drugs. Methyl chloride was
believed to be contribute to the rapidity of induction of general anesthesia, ethyl chloride to
maintenance of anesthesia and ethyl bromide to postoperative analgesia. It was so easy to administer that
formal medical training was considered unnecessary. The pulse appeared to strength under somnoforme
anesthesia and depth of anesthesia would briefly increase after removal of the mask which was
particularly advantageous for dental procedures.
However, enthusiasm for somnoforme was transient. In part, this was because somnoforme failed to
meet the contemporary definition of an ideal anesthetic gas since it had significant potential toxicity.
In part, this was because E. de Trey & Sons were accused and pleaded guilty to the charge by the United
States Government of mislabeling their product (newly a crime under the Pure Food & Drug Act of
1906) since it failed to contain any ethyl bromide. And finally, this in part due to the fact the desired
attributes of the ideal anesthetic gas have evolved over time to include nonflammability. After a brief
period of enthusiasm, Somnoforme saw limited use until it was totally abandoned in 1931.

INTRODUCTION:

In fact, Dr. Rolland allowed himself to be anesthetized with somnoforme while
his radial artery pulse was monitored with a sphygmograph. The resultant
pre-anesthesia and intra-anesthesia pulse tracings (figure 2) were published in
the Journal of the British Dental Association in 1902 and demonstrated an
increased amplitude of the arterial waveform under anesthesia.5 This made
somnoforme remarkably different than ether or chloroform.
In patients receiving somnoforme by inhalation, blood pressure increased
without significant change in heart rate or respiratory rate6 (figure 3). Rapid
inhalational induction without excitation was viewed an important advantage
over contemporary anesthetics.7 The de Trey inhaler was the preferred delivery
device since it was light-weight, simple, and resistant to damage. (figure 4)
Somnoforme was conveniently packaged in small ampoules (figures 5) as
opposed to nitrous oxide which required larger and more awkward containers.
The tapered end of the glass ampoule would be broken within the handle of the
inhaler, soaking the cotton with the highly volatile somnoforme liquid.8
(figure 6) The patient would be instructed to breathe deeply from the face mask
for up to 30 seconds, but induction of anesthesia rarely took more than 20 seconds. With the reservoir bag attached, the apparatus formed a closed system to
prevent the escape of the volatile somnoforme; room air was not entrained into
the system and the patient was rebreathing all expired gases. Some somnoforme
inhalers were designed to allow the optional entrainment of room air for use in
longer procedures. After removal of the face mask, depth of anesthesia appeared
to briefly deepen, which was particularly useful for dental procedures performed
prior to the advent of endotracheal intubation.

Less than a year after Morton’s public demonstration of ether anesthesia, the
first mortality from ether was reported. The first chloroform-related fatality was
reported a year later. The recognition that ether and chloroform were imperfect
agents that could harm created a keen interest to develop the ideal anesthetic
gas. At the beginning of the 20th century, the search for the ideal anesthetic was
focused upon finding an anesthetic gas with rapid inhalational induction and
rapid emergence that could be delivered without “cumbersome apparatus” and
would have limited potential for morbidity or mortality.1

Somnoforme was well-received by patients. Although disorientation on
emergence from anesthesia was common, patients rarely reported dysphoria.
The sensation was typically described as “gaiety, joy, rapture, anger, or religious
ecstasy.”9

THE RISE OF SOMNOFORME:

However, clinical enthusiasm for somnoforme was short-lived. It received
limited usage outside of dentistry and even dentists quickly abandoned the
anesthetic whose properties they had initially praised. Four factors caused this.
First, the general anesthetic effects of the primary component, ethyl chloride,
were extremely transient and without significant muscle relaxation, so the
anesthetic efficacy was limited to dental or brief superficial procedures.
Secondly, the mixing of several gases did not mitigate the dangers of the
individual components and ethyl chloride was found to have a safety profile
comparable to chloroform.10 Chloroform was generally considered too
dangerous for administration by dentists. Thirdly, the reputation of somnoforme
was irreparably tarnished when an American distributor was discovered to be
intentionally omitting the ethyl bromide component. Mislabeling
pharmaceutical products was a newly designated crime under the Pure Food &
Drug Act of 1906. E. de Trey & Sons pled guilty to this charge after government
chemists analyzed the somnoforme being sold in the US and failed to detect any
ethyl bromide.11,12 And finally, the desired attributes of the ideal anesthetic gas
expanded to include nonflammability after the introduction of electrocautery to
surgical procedures in 1926. After a brief decade of clinical popularity,
somn forme saw diminishing use until it was totally abandoned in 1931.

Somnoforme was developed by Dr. George Rolland, Director of the Bordeaux
Dental School and first formally presented to the Congress of the French
Association for the Advancement of Sciences on September 10, 1901.
Somnoforme was a mixture of ethyl chloride (60%), methyl chloride (35%), and
ethyl bromide (5%) designed to provide powerful efficacy with low potential for
side effects by combining several anesthetic gases. Dr Rolland’s goal was “to
blend already well-known drugs into one mixture from which the respective
advantages of each one could be obtained and corresponding effects produced
without having many of the inconveniences and the same degree of danger of
the individual drugs.”2 Methyl chloride was believed to contribute to the
rapidity of induction of general anesthesia, ethyl chloride to maintenance of
anesthesia and ethyl bromide to postoperative analgesia.
The major American distributor for somnoforme, E. de Trey & Sons of
Philadelphia, advertised it as “the ideal general anesthetic for dental and minor
surgical operations.”3 (figure 1) This sentiment was echoed in the scientific
literature which soon lauded somnoforme as “the ideal general anesthetic for
short operations.”4 It was so safe and easy to administer that formal medical
training was considered unnecessary. The pulse appeared to strengthen under
somnoforme anesthesia.

THE DEMISE OF SOMNOFORME:

Figure 3. The hemo-dynamic effects of Somnoforme. 6
Figure 3. The hemodynamic effects of
Somnoforme. 6

Figure 6. Internal schematics of the de
Trey inhaler as depicted by Dr. William H.
de Ford. Dr. de Ford de-livered tens of
thousands of somnoforme anesthetics
and later introduced a somnoforme inhaler
bearing his name, the de Ford inhaler.

Figure 1. Journal advertisement from 1906.

Figure 5. An ampoule of highly volatile
somnoforme (from the collection of the
author)

Figure 2. Dr. Rolland’s radial artery pulse wave under
somnoforme anesthesia.5

CONCLUSIONS:
In retrospect, the proclamation of the formulation of an “ideal anesthetic” was
premature as that search continues to this day. However, even some
contemporary physicians were skeptical and offered sage wisdom which endures
a century later. In response to claims of new “safe” anesthetics, an editorial in
The Medical Times from January 1908 came to this astonishingly modern
conclusion.
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